Guidance on FDA Regulatory Requirements for Indian Pharmaceutical Industry 䀂 Approval process for FDA ٴ Submissions ٴ Process Validation ٴ Clinical Trials
Overview: In this session, attendees will learn what the PCI DSS requires for protection and how the PCI DSS relates to the HIPAA Security Rule - there are substantial similarities, and being ...
Why you should attend: This webinar will help the participants understand what a Pharmaceutical Quality System is and how to transition from the compliance systems of today to the systems outlined in ...
Overview: Although the concept of test method validation is based on good science, the expectation that test methods in the pharmaceutical industry be validated was established by the USP in the ...
Medical Device Classification - US and the EU as per MDD, CMDR and GHTF - Webinar By GlobalCompliancePanel
Why should you attend: Attendees will learn what their Risk Analysis and Security Analysis obligations are under HIPAA and the new "meaningful use" rules under the HITECH Act. Attendees will receive ...
Overview: Laboratory equipment should be calibrated and/or qualified to demonstrate suitability for the intended use. Laboratory systems including equipment are amongst key targets of FDA ...
If you have participated in hazard analysis meetings, you have probably spent hours discussing whether a scenario is a hazard, or the cause of a hazard, or debating whether the probability of an ...
This presentation will review the QSR and ISO requirements for supplier evaluation and assessment, and provide cost efficient, equally compliant options to many of the most common practices
This webinar will examine the existing and proposed requirements for the FDA's DHF -- including its derivative documents, the DMR and DHR